* Aethlon Medical Inc reported a quarterly adjusted loss of 91 cents per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of $-1.00. The mean expectation of three analysts for the quarter was for a loss of $1.23 per share. Wall Street expected results to range from $-1.41 to $-1.10 per share.
* Reported revenue was zero; analysts expected zero.
* Aethlon Medical Inc's reported EPS for the quarter was a loss of 91 cents.
* The company reported a quarterly loss of $2.43 million.
* Aethlon Medical Inc shares had fallen by 65.2% this quarter and lost 73.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by about 2% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced medical equipment & technology peer group is "hold."
Wall Street's median 12-month price target for Aethlon Medical Inc is $5.25 This summary was machine generated from LSEG data June 27 at 09:35 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -1.23 -0.91 Beat
Dec. 31 2023 -1.23 -1.37 Missed
Sep. 30 2023 -1.40 -1.22 Beat
Jun. 30 2023 -1.30 -1.40 Missed
Comments